A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Oncolytics Biotech, Inc’s current trading price is -18.30% away from its 52-week high, while its distance from the 52-week low is 283.67%. The stock’s price range for this time frame has been between $0.33 and $1.53. The trading volume of the company’s shares in the Healthcare reached around 1.76 million for the day, which was evidently higher than the average daily volume of 1.02 million over the last three months.
Oncolytics Biotech, Inc (ONCY) has a current stock price of $1.25. During the previous trading session, the stock witnessed a notable rise, reaching a high of $5.09 after opening at $1.25. The stock’s low for the day was $3.06, and it eventually closed at $1.13.
In terms of market performance, Oncolytics Biotech, Inc had a somewhat regular. The highest value for the stock in the past year was $1.53 on 10/07/24, while the lowest value was $0.33 on 06/06/25.
How Financial Performance Impacts Market Capitalization
Oncolytics Biotech, Inc (ONCY) has experienced a quarterly rise of 111.86% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 120.75M and boasts a workforce of 28 employees.
Decoding Analysts’ Ratings for Oncolytics Biotech, Inc
As of right now, 1 analyst is rating Oncolytics Biotech, Inc as a BUY, 4 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6220, with a change in price of +0.5112. Similarly, Oncolytics Biotech, Inc recorded 754,370 in trading volume during the last 100 days, posting a change of +69.19%.
How ONCY’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ONCY stands at 0.15. Similarly, the long-term debt-to-equity ratio is also 0.11.
ONCY Stock Stochastic Average
Oncolytics Biotech, Inc’s raw stochastic average for the past 50 days is currently at 93.90%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 91.99%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 84.55% and 83.00%, respectively.
ONCY Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The index has shown a price gain of 20.19% this year. Over the last six months, there has been a weaker performance of 50.33%. The price of ONCY fallen by 105.59% during the last 30 days period. For the last 5-days stocks have improved 4.17%.
